Solvonis

Solvonis is developing novel treatments for addiction and mental health conditions through a combination of ketamine and cognitive behavioural therapy. With Phase 3 trials coming up, it’s one to watch.

Addiction and mental health conditions can be emotive subjects. But here, that’s not the focus. Neither is the use of ketamine. It’s all about the science and the results to date, with precise, grounded copy that calmly builds investor confidence in the brand’s mission and pipeline.